Bone marrow dendritic cell-based anticancer vaccines.
Indrová
M
M
Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 16637 Prague 6, Czech Republic.
Mendoza
L
L
Reinis
M
M
Vonka
V
V
Smahel
M
M
Nĕmecková
S
S
Jandlová
T
T
Bubeník
J
J
D000595:Amino Acid Sequence; D000818:Animals; D017951:Antigen Presentation; D000957:Antigens, Viral, Tumor / Q000008:administration & dosage; D001854:Bone Marrow Cells / Q000276:immunology; D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology*; D002460:Cell Line; D003713:Dendritic Cells / Q000276:immunology*; D016056:Immunodominant Epitopes / Q000008:administration & dosage; D066298:In Vitro Techniques; D008213:Lymphocyte Activation; D051379:Mice; D008810:Mice, Inbred C57BL; D009856:Oncogene Proteins, Viral / Q000008:administration & dosage / Q000276:immunology; D050725:Papillomavirus E7 Proteins; D010446:Peptide Fragments / Q000008:administration & dosage / Q000276:immunology
D000957:Antigens, Viral, Tumor; D019496:Cancer Vaccines; D016056:Immunodominant Epitopes; D009856:Oncogene Proteins, Viral; D050725:Papillomavirus E7 Proteins; D010446:Peptide Fragments; C059731:oncogene protein E7, Human papillomavirus type 16